Paired box 2 upregulates androgen receptor gene expression in androgen-independent prostate cancer

被引:9
作者
Ito, Saya [1 ]
Ueda, Takashi [1 ]
Ueno, Akihisa [1 ]
Nakagawa, Hideo [1 ]
Taniguchi, Hidefumi [1 ]
Hongo, Fumiya [1 ]
Kamoi, Kazumi [1 ]
Okihara, Koji [1 ]
Kawauchi, Akihiro [1 ]
Miki, Tsuneharu [1 ]
机构
[1] Kyoto Prefectural Univ Med, Dept Urol, Kyoto 6028566, Japan
关键词
androgen receptor; DNA methylation; gene expression; PAX2; prostate cancer; CARCINOMA-CELL-LINE; UPSTREAM ENHANCER; ANTIGEN PROMOTER; DNA-BINDING; PAX2; METHYLATION; ACTIVATION; REGION; TRANSCRIPTION; RECRUITMENT;
D O I
10.1111/febs.12959
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Androgen-independent prostate cancer is known as a hormone-refractory disease. Although the androgen receptor (AR) is considered to be a key regulator of androgen-independent prostate cancer progression, the mechanism through which AR gene expression is regulated is not well understood. In the present study, we showed that the AR gene was upregulated by paired box 2 (PAX2) in androgen-independent prostate cancer. When PAX2 upregulated AR gene expression, a decrease in DNA methylation of the AR gene locus was also observed. PAX2 was highly expressed and promoted cell growth in an androgen-independent prostate cancer cell line (22Rv1). The cell growth inhibition by PAX2 knockdown was rescued by AR overexpression in 22Rv1 cells. In a mouse xenograft model of androgen-independent prostate cancer, PAX2 knockdown inhibited tumor growth and AR gene expression and also increased DNA methylation of the AR gene. Consistent with this, AR and PAX2 expression levels were positively correlated in prostate cancer patients. These findings suggested that PAX2 promoted cancer cell growth in androgen-independent prostate cancer by regulating AR gene expression through an epigenetic mechanism.
引用
收藏
页码:4506 / 4518
页数:13
相关论文
共 44 条
[31]   A gene atlas of the mouse and human protein-encoding transcriptomes [J].
Su, AI ;
Wiltshire, T ;
Batalov, S ;
Lapp, H ;
Ching, KA ;
Block, D ;
Zhang, J ;
Soden, R ;
Hayakawa, M ;
Kreiman, G ;
Cooke, MP ;
Walker, JR ;
Hogenesch, JB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (16) :6062-6067
[32]   Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1 [J].
Tahiliani, Mamta ;
Koh, Kian Peng ;
Shen, Yinghua ;
Pastor, William A. ;
Bandukwala, Hozefa ;
Brudno, Yevgeny ;
Agarwal, Suneet ;
Iyer, Lakshminarayan M. ;
Liu, David R. ;
Aravind, L. ;
Rao, Anjana .
SCIENCE, 2009, 324 (5929) :930-935
[33]   Expression and Role of HMGA1 in Renal Cell Carcinoma [J].
Takaha, Natsuki ;
Sowa, Yoshihiro ;
Takeuchi, Ichiro ;
Hongo, Fumiya ;
Kawauchi, Akihiro ;
Miki, Tsuneharu .
JOURNAL OF UROLOGY, 2012, 187 (06) :2215-2222
[34]   Alternative splicing in PAX2 generates a new reading frame and an extended conserved coding region at the carboxy terminus [J].
Tavassoli, K ;
Rüger, W ;
Horst, J .
HUMAN GENETICS, 1997, 101 (03) :371-375
[35]  
Tepper CG, 2002, CANCER RES, V62, P6606
[36]  
THALMANN GN, 1994, CANCER RES, V54, P2577
[37]   Hyper-expression of PAX2 in human metastatic prostate tumors and its role as a cancer promoter in an in vitro invasion model [J].
Ueda, Takashi ;
Ito, Saya ;
Shiraishi, Takumi ;
Kulkarni, Prakash ;
Ueno, Akihisa ;
Nakagawa, Hideo ;
Kimura, Yasunori ;
Hongo, Fumiya ;
Kamoi, Kazumi ;
Kawauchi, Akihiro ;
Miki, Tsuneharu .
PROSTATE, 2013, 73 (13) :1403-1412
[38]   Spatial and temporal recruitment of androgen receptor and its coactivators involves chromosomal looping and polymerase tracking [J].
Wang, QB ;
Carroll, JS ;
Brown, M .
MOLECULAR CELL, 2005, 19 (05) :631-642
[39]  
WARD TA, 1994, CELL GROWTH DIFFER, V5, P1015
[40]   Activation functions 1 and 2 of nuclear receptors:: Molecular strategies for transcriptional activation [J].
Wärnmark, A ;
Treuter, E ;
Wright, APH ;
Gustafsson, JÅ .
MOLECULAR ENDOCRINOLOGY, 2003, 17 (10) :1901-1909